Cholestyramine

考来烯胺

Report date: 2023/02/21 16:23:23
NME

Base Information

Drug NameCholestyramine
Drug Alias NameColestyramineColestiraminaColestyraminumQuestranQuantalan +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsHypercholesterolemiaHyperlipidemiasHyperlipoproteinemia Type II +[9] 
Global Approved IndicationsHypercholesterolemiaHyperlipidemias
Approved Indications in ChinaHypercholesterolemia
Original Approved Country/TerritoryCanada
Original Approved Date1965/04/02
Country/TerritoryCanadaUnited StatesPoland +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesSanofiNanjing Lifecare Pharmaceutical Co Ltd
Inactive CompaniesPharmascience IncNational Heart, Lung, And Blood Institute (Nhlbi)Bristol-Myers Squibb Company
Active IndicationsHypercholesterolemia
Inactive IndicationsHyperlipidemiasHyperlipoproteinemia Type IIMyocardial Infarction +[8] 

Other Information

ATC CodeC10AC01
Related LinksWikipediaDrugBankKEGG